Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: High response rates in a phase II clinical trial

C. B. Reeder, D. E. Reece, V. Kukreti, C. Chen, S. Trudel, J. Hentz, B. Noble, N. A. Pirooz, J. E. Spong, J. G. Piza, V. H.J. Zepeda, J. R. Mikhael, J. F. Leis, P. L. Bergsagel, R. Fonseca, A. K. Stewart

Research output: Contribution to journalArticlepeer-review

281 Scopus citations

Fingerprint Dive into the research topics of 'Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: High response rates in a phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences